Planning Strategies Inc.’s Vaxcyte PCVX Stock Holding History

Planning Strategies Inc.’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$116	Buy	+2	New	+$109	﹤0.01%	1025

Other funds holding PCVX

NFT

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

BAAM

Baker Avenue Asset Management San Francisco, California $5.28B AUM 39.19% 1-Year Est. Return

MGWM

Marks Group Wealth Management Minnetonka, Minnesota $1.15B AUM 16.94% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

Planning Strategies Inc.'s PCVX Position: Q2 2026 in Review

Planning Strategies Inc. opened a new position in Vaxcyte (PCVX) in Q2 2026: 2 shares worth $116. The stake represents ﹤0.01% of the portfolio and ranks #1025 among its holdings.

51 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

Planning Strategies Inc. held 2 shares of Vaxcyte worth $116 as of Q2 2026.
Vaxcyte was a new Planning Strategies Inc. position in Q2 2026.
Vaxcyte made up ﹤0.01% of Planning Strategies Inc.'s portfolio in Q2 2026, its #1025 holding.
51 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Planning Strategies Inc.'s 13F filing for Q2 2026, filed 27 Jul 2026.